论文部分内容阅读
目的:探讨联合布地奈德混悬液与清肺消炎丸治疗毛细支气管炎的临床疗效。方法:选择2015年1月—2015年12月在我院治疗的毛细支气管炎患儿100例的临床资料进行回顾性分析。对照组48例给予止咳、抗感染、平喘、祛痰、镇静、吸氧及对症支持治疗,研究组52例在对照组治疗基础上加用雾化吸入布地奈德混悬液及清肺消炎丸治疗。比较两组的临床疗效及症状体征缓解时间。结果:研究组治愈率更高,总有效率显著高于对照组(P<0.05)。研究组肺部湿罗音消失时间、喘憋消失时间、喘鸣音消失时间均显著低于对照组,差异有显著统计学意义(P<0.01)。两组均无明显的不良反应情况。结论:在常规治疗基础上给予布地奈德混悬液吸入联合清肺消炎丸治疗毛细支气管炎能够提高患者临床疗效,缩短症状体征缓解时间。
Objective: To investigate the clinical efficacy of budesonide suspension combined with Qingfei Xiaoyan Pill in the treatment of bronchiolitis. Methods: The clinical data of 100 children with bronchiolitis treated in our hospital from January 2015 to December 2015 were retrospectively analyzed. The control group of 48 cases given cough, anti-infective, antiasthmatic, expectorant, sedative, oxygen and symptomatic and supportive treatment, the study group 52 cases in the control group based on the treatment plus inhalation of budesonide suspension and Qingfei anti-inflammatory Pill treatment. The clinical efficacy and symptom and symptom relief time of the two groups were compared. Results: The study group had a higher cure rate and a higher total effective rate than the control group (P <0.05). The lung wet rales disappear time, wheezing disappear time and wheezing disappeared in the study group were significantly lower than the control group, the difference was statistically significant (P <0.01). No significant adverse reactions in both groups. Conclusion: The administration of budesonide suspension combined with Qingfei Xiaoyan Pills in the treatment of bronchiolitis on the basis of routine treatment can improve the clinical curative effect and shorten the time of symptom and symptom relief.